Cost–Utility Analysis of Antihemophilic Factor Rfviii-Fs for Secondary Prophylaxis Vs on-Demand Therapy In Severe Haemophilia A In Italy
Nov 1, 2015, 00:00
10.1016/j.jval.2015.09.1974
https://www.valueinhealthjournal.com/article/S1098-3015(15)04050-4/fulltext
Title :
Cost–Utility Analysis of Antihemophilic Factor Rfviii-Fs for Secondary Prophylaxis Vs on-Demand Therapy In Severe Haemophilia A In Italy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)04050-4&doi=10.1016/j.jval.2015.09.1974
First page :
A671
Section Title :
Research Podium Presentations - Session 1 and Session 2
Open access? :
No
Section Order :
1867